1. Home
  2. TEX vs HALO Comparison

TEX vs HALO Comparison

Compare TEX & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terex Corporation

TEX

Terex Corporation

HOLD

Current Price

$64.45

Market Cap

7.6B

Sector

Industrials

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$68.04

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEX
HALO
Founded
1933
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.8B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
TEX
HALO
Price
$64.45
$68.04
Analyst Decision
Buy
Buy
Analyst Count
10
11
Target Price
$68.80
$78.18
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
05-01-2026
05-05-2026
Dividend Yield
1.07%
N/A
EPS Growth
N/A
N/A
EPS
3.33
2.56
Revenue
$5,421,000,000.00
$151,862,000.00
Revenue This Year
$47.68
$28.24
Revenue Next Year
$6.81
$12.79
P/E Ratio
$19.02
$26.18
Revenue Growth
5.73
N/A
52 Week Low
$33.13
$47.50
52 Week High
$71.50
$82.22

Technical Indicators

Market Signals
Indicator
TEX
HALO
Relative Strength Index (RSI) 57.74 57.42
Support Level $58.60 $67.02
Resistance Level $70.58 $74.92
Average True Range (ATR) 2.33 1.69
MACD 0.79 0.83
Stochastic Oscillator 93.53 96.68

Price Performance

Historical Comparison
TEX
HALO

About TEX Terex Corporation

Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: